320 related articles for article (PubMed ID: 31317824)
21. Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature.
Kahriman A; Bouley J; Smith TW; Bosco DA; Woerman AL; Henninger N
Acta Neuropathol Commun; 2021 Jun; 9(1):118. PubMed ID: 34187585
[TBL] [Abstract][Full Text] [Related]
22. Involvement of tau phosphorylation in traumatic brain injury patients.
Yang WJ; Chen W; Chen L; Guo YJ; Zeng JS; Li GY; Tong WS
Acta Neurol Scand; 2017 Jun; 135(6):622-627. PubMed ID: 27439764
[TBL] [Abstract][Full Text] [Related]
23. Biological links between traumatic brain injury and Parkinson's disease.
Delic V; Beck KD; Pang KCH; Citron BA
Acta Neuropathol Commun; 2020 Apr; 8(1):45. PubMed ID: 32264976
[TBL] [Abstract][Full Text] [Related]
24. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.
Alyenbaawi H; Allison WT; Mok SA
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33121065
[TBL] [Abstract][Full Text] [Related]
25. Role of Caspase-3-Mediated Apoptosis in Chronic Caspase-3-Cleaved Tau Accumulation and Blood-Brain Barrier Damage in the Corpus Callosum after Traumatic Brain Injury in Rats.
Glushakova OY; Glushakov AO; Borlongan CV; Valadka AB; Hayes RL; Glushakov AV
J Neurotrauma; 2018 Jan; 35(1):157-173. PubMed ID: 28637381
[TBL] [Abstract][Full Text] [Related]
26. Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.
Ikonomovic MD; Mi Z; Abrahamson EE
Ageing Res Rev; 2017 Mar; 34():51-63. PubMed ID: 27829172
[TBL] [Abstract][Full Text] [Related]
27. Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury.
Niziolek GM; Boudreau RM; Baker J; Friend LA; Makley AT; Edwards MJ; Gulbins E; Goodman MD
J Neurotrauma; 2020 Sep; 37(17):1902-1909. PubMed ID: 32138594
[TBL] [Abstract][Full Text] [Related]
28. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
[TBL] [Abstract][Full Text] [Related]
29. Exosome-associated tau exacerbates brain functional impairments induced by traumatic brain injury in mice.
Wang B; Han S
Mol Cell Neurosci; 2018 Apr; 88():158-166. PubMed ID: 29408549
[TBL] [Abstract][Full Text] [Related]
30. Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature.
Walker A; Chapin B; Abisambra J; DeKosky ST
Acta Neuropathol Commun; 2022 Jan; 10(1):13. PubMed ID: 35101132
[TBL] [Abstract][Full Text] [Related]
31. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury.
Cao J; Gaamouch FE; Meabon JS; Meeker KD; Zhu L; Zhong MB; Bendik J; Elder G; Jing P; Xia J; Luo W; Cook DG; Cai D
Sci Rep; 2017 Sep; 7(1):11372. PubMed ID: 28900205
[TBL] [Abstract][Full Text] [Related]
32. Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.
Johnson NR; Condello C; Guan S; Oehler A; Becker J; Gavidia M; Carlson GA; Giles K; Prusiner SB
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11029-E11036. PubMed ID: 29203673
[TBL] [Abstract][Full Text] [Related]
33. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
Baker S; Polanco JC; Götz J
J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
[TBL] [Abstract][Full Text] [Related]
34. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
35. The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation.
Wang Y; Hall RA; Lee M; Kamgar-Parsi A; Bi X; Baudry M
Sci Rep; 2017 Sep; 7(1):11771. PubMed ID: 28924170
[TBL] [Abstract][Full Text] [Related]
36. Tau progression in single severe frontal traumatic brain injury in human brains.
Okamura Y; Kawakami I; Watanabe K; Oshima K; Niizato K; Ikeda K; Akiyama H; Hasegawa M
J Neurol Sci; 2019 Dec; 407():116495. PubMed ID: 31655411
[TBL] [Abstract][Full Text] [Related]
37. Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.
Liu K; Liu Y; Li L; Qin P; Iqbal J; Deng Y; Qing H
Biochim Biophys Acta; 2016 Feb; 1862(2):192-201. PubMed ID: 26655600
[TBL] [Abstract][Full Text] [Related]
38. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
Okuda M; Hijikuro I; Fujita Y; Wu X; Nakayama S; Sakata Y; Noguchi Y; Ogo M; Akasofu S; Ito Y; Soeda Y; Tsuchiya N; Tanaka N; Takahashi T; Sugimoto H
PLoS One; 2015; 10(2):e0117511. PubMed ID: 25659102
[TBL] [Abstract][Full Text] [Related]
39. Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Rodrigues S; Anglada-Huguet M; Hochgräfe K; Kaniyappan S; Wegmann S; Mandelkow EM
J Mol Neurosci; 2023 Oct; 73(9-10):693-712. PubMed ID: 37606769
[TBL] [Abstract][Full Text] [Related]
40. Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury.
Du X; West MB; Cheng W; Ewert DL; Li W; Saunders D; Towner RA; Floyd RA; Kopke RD
Oxid Med Cell Longev; 2016; 2016():4159357. PubMed ID: 27034735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
